ZYME insider trading
Open-market stock trades by Zymeworks (ZYME) executives and directors: who bought or sold, how many shares, at what price and when.
ZYME insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | Schayowitz Adam | EVP, Head of R&D | Sell | 13,832 | $25.85 | $357.56K |
| Jan 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | Sell | 6,120 | $22.67 | $138.76K |
| Jan 12, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | Sell | 9,310 | $22.67 | $211.09K |
| Jan 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | Sell | 9,560 | $22.67 | $216.76K |
| Jan 12, 2026 | Galbraith Kenneth | Chair & CEO | Sell | 30,424 | $22.67 | $689.82K |
| Jan 5, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | Sell | 10,538 | $25.10 | $264.47K |
| Jan 5, 2026 | Galbraith Kenneth | Chair & CEO | Sell | 31,686 | $25.10 | $795.22K |
| Jan 5, 2026 | Galbraith Kenneth | Chair & CEO | Sell | 22,657 | $25.10 | $568.62K |
| Jan 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | Sell | 10,821 | $25.10 | $271.57K |
| Jan 5, 2026 | Moore Paul Andrew | Chief Scientific Officer | Sell | 9,289 | $25.10 | $233.13K |
| Dec 22, 2025 | Galbraith Kenneth | Chair & CEO | Sell | 47,528 | $27.02 | $1.28M |
- ZYME insiders bought $0.00 and sold $5.03M in open-market trades over their last 11 filings.
Updated 2026-11-03 02:02 UTC